CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 29.88

CSPC Innovation Pharmaceutical Co., Ltd. experienced a notable decline in its stock performance on March 3, 2026, with a loss of 4.36%. The stock reached an intraday low of CNY 29.88, reflecting ongoing challenges within the company. Over the past week, CSPC has seen a significant drop of 10.2%, and its performance over the last month has declined by 19.3%. In a broader context, CSPC's one-year performance shows a decrease of 12.55%, contrasting sharply with the China Shanghai Composite, which has gained 22.49% during the same period. The company's market capitalization stands at CNY 47,166 million, categorizing it as a large-cap entity within the fast-moving consumer goods (FMCG) sector. Financial metrics indicate a concerning trend, with net profit for the first half of the year reported at CNY -3.33 million, reflecting a growth rate of -102.43%. Additionally, the return on equity is at -15.39%, highlighting the company's current financial difficulties. As CSPC navigates these challenges, its stock performance continues to attract attention in the market.